LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ:ITEK), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for ocular diseases, today announced that David P. Southwell, President and Chief Executive Officer of Inotek, will participate in an ophthalmology panel at the 18th Annual BIO CEO & Investor Conference. The panel will take place in New York City at the Waldorf Astoria Hotel on Monday, February 8, 2016 at 9:30 am EST.
